Decisions
| Date | Case | Division | Action | Motion | Outcome | Summary |
|---|---|---|---|---|---|---|
| 2024-06-21 | UPC_APP_35134/2024 | The Hague LD | Generic application | Procedural | Procedural only | The Hague Local Division rejected a request for simultaneous interpretation facilities between English and Polish at the oral hearing in the Amycel v. Spyra preliminary injunction proceedings, but granted a different request for interpretation under Rule 109.4 RoP after applying the double appropriateness test. |
| 2024-02-12 | UPC_CFI_395/2023 | Paris LD | Generic Order | Procedural | Procedural only | Procedural order from the Paris Local Division granting an extension and alignment of deadlines for filing the Statement of Defence in an infringement action by DexCom against 14 Abbott group defendants. The parties had orally agreed on a filing date at a case management meeting, which the Judge-Rapporteur considered reasonable. The order also confirmed service completion details for each defendant. |
| 2024-01-30 | UPC_CFI_230/2023 | Paris LD | Infringement Action | Procedural | Procedural only | The Paris Local Division panel, on review under Rule 333 RoP, partially upheld Abbott's application by increasing the upper limit of the penalty for breach of the confidentiality club from EUR 50,000 to EUR 250,000, to achieve consistency with a parallel confidentiality order issued by the Munich Local Division in related proceedings. |
| 2024-01-24 | UPC_CFI_230/2023 | Paris LD | Infringement Action | Procedural | Procedural only | The Paris Local Division full panel issued a procedural order in the Dexcom v. Abbott infringement case, rejecting Abbott's request for leave to appeal the judge-rapporteur's confidentiality order of 19 December 2023, finding it was a case management order subject to Rule 333 RoP review rather than a directly appealable order. |
| 2023-12-19 | UPC_CFI_230/2023 | Paris LD | Infringement Action | Procedural | Procedural only | The Paris Local Division issued a procedural order in an infringement action brought by DexCom against multiple Abbott entities, granting Abbott's request to protect certain highly sensitive sales and revenue information contained in Abbott's statement of defence from public access. |